World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
55
Citations
9256
World Ranking
12301
National Ranking
905

Joel C. Barrish publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Joel C. Barrish sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 214 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Joel C. Barrish D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Joel C. Barrish sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 55 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Joel C. Barrish is affiliated with Bristol-Myers Squibb (Germany) in Germany. Their research spans multiple fields including Biochemistry, Genetics and Molecular Biology, as well as Medicine.

The scientist's work covers a variety of subfields such as Materials Chemistry, Molecular Biology, Biochemistry, Surgery, and Endocrinology, Diabetes and Metabolism.

Main topics in their research include

  • Amino Acid Enzymes and Metabolism
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography
  • Metabolism and Genetic Disorders
  • Pancreatic function and diabetes
  • Diabetes Treatment and Management
  • Biochemical and Molecular Research

Joel C. Barrish has contributed to a range of recent publications, including the following:

  • BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate (2021), published in ACS Medicinal Chemistry Letters
  • Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of Psoriasis (2020), published in ACS Medicinal Chemistry Letters
  • Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132) (2022), published in Journal of Medicinal Chemistry
  • SLC6A19 inhibition facilitates urinary neutral amino acid excretion and lowers plasma phenylalanine (2024), published in JCI Insight
  • Driving Potency with Rotationally Stable Atropisomers: Discovery of Pyridopyrimidinedione-Carbazole Inhibitors of BTK (2020), published in ACS Medicinal Chemistry Letters

Frequent co-authors of Joel C. Barrish include

  • Arvind Mathur
  • Percy H. Carter
  • Nick Pullen
  • Dean G. Brown
  • Dauh-Rurng Wu

They publish regularly in venues such as

  • The Cambridge Structural Database
  • ACS Medicinal Chemistry Letters
  • Molecular Genetics and Metabolism
  • Journal of Medicinal Chemistry
  • JCI Insight

Best Publications

  • Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays.

    Louis J. Lombardo;Francis Y. Lee;Ping Chen;Derek Norris

  • 2-aminothiazole as a novel kinase inhibitor template. Structure-activity relationship studies toward the discovery of N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1- piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor.

    Jagabandhu Das;Ping Chen;Derek Norris;Ramesh Padmanabha

  • Cyclic protein tyrosine kinase inhibitors

    Jagabandhu Das;Ramesh Padmanabha;Ping Chen;Derek J. Norris

  • A new facile method for the synthesis of 1-arylimidazole-5-carboxylates

    Bang-Chi Chen;Mark S Bednarz;Rulin Zhao;Joseph E Sundeen

  • A stereoselective synthesis of 1,3-diol derivatives and application to the ansa bridge of rifamycin S

    W. Clark Still;Joel C. Barrish

  • Discovery and preclinical studies of (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol (BMS-540215), an in vivo active potent VEGFR-2 inhibitor.

    Rajeev S. Bhide;Zhen-Wei Cai;Yong-Zheng Zhang;Ligang Qian

  • Discovery of brivanib alaninate ((S)-((R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), a novel prodrug of dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 kinase inhibitor (BMS-540215).

    Zhen-wei Cai;Yongzheng Zhang;Robert M. Borzilleri;Ligang Qian

  • Selective Itk Inhibitors Block T-Cell Activation and Murine Lung Inflammation

    Tai An Lin;Kim W. McIntyre;Jagabandhu Das;Chunjian Liu

  • Discovery of 2-amino-heteroaryl-benzothiazole-6-anilides as potent p56lck inhibitors

    Jagabandhu Das;Robert V. Moquin;James Lin;Chunjian Liu

  • Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton's Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers.

    Scott H. Watterson;George V. De Lucca;Qing Shi;Charles M. Langevine

  • METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS

    Katerina Leftheris;Joel Barrish;John Hynes;Stephen T. Wrobleski

  • Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors

    Ping Chen;Derek J. Norris;Joel C. Barrish;Edwin J. Iwanowicz

  • Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors.

    Jagabandhu Das;Joseph A. Furch;Chunjian Liu;Robert V. Moquin

  • Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors.

    John Hynes;Alaric J. Dyckman;Shuqun Lin;Stephen T. Wrobleski

  • Dual action inhibitors

    Donald S. Karanewsky;Joel C. Barrish;Edward W. Petrillo;Jeffrey A. Robl

  • Amino Diol HIV Protease Inhibitors. 1. Design, Synthesis, and Preliminary SAR

    Joel C. Barrish;Eric Gordon;Masud Alam;Pin-Fang Lin

  • 5-Cyanopyrimidine derivatives as a novel class of potent, selective, and orally active inhibitors of p38alpha MAP kinase.

    Chunjian Liu;Stephen T. Wrobleski;James Lin;Gulzar Ahmed

  • Cupric bromide mediated oxidation of 4-carboxyoxazolines to the corresponding oxazoles

    Joel C. Barrish;Janak Singh;Steven H. Spergel;Wen Ching Han

  • Substituted biphenyl sulfonamide endothelin antagonists

    Natesan Murugesan;Joel C. Barrish;Philip D. Stein

  • Imidazoquinoxaline protein tyrosine kinase inhibitors

    Joel C. Barrish;Ping Chen;Jagabandhu Das;Edwin J. Iwanowicz

Frequent Co-Authors

Gary L. Schieven
Gary L. Schieven Genesis Biotechnology Group
John T. Hunt
John T. Hunt Bristol-Myers Squibb (Germany)
Diane Hollenbaugh
Diane Hollenbaugh Bonum Therapeutics
James R. Burke
James R. Burke Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to various specialized fields, including forensic science and related careers. For students interested in combining their chemistry knowledge with legal investigations, exploring the autopsy technician salary and job outlook can provide valuable insights. This career blends scientific techniques with medical examinations to support legal systems.

For those seeking affordable education options, many online programs offer degrees tailored to forensic sciences. The cheapest online forensic science degree programs provide flexible learning paths without compromising quality, ideal for working professionals or remote learners.

Graduate studies in areas like forensic psychology are also gaining popularity. Exploring forensic psychology graduate programs online offers students the chance to specialize further, combining their chemistry background with behavioral science to assist in criminal investigations.

Career-wise, forensic science offers diverse opportunities with competitive compensation. Understanding the forensic scientist salary landscape helps guide career decisions and highlights the financial potential within this scientific field.

Best Scientists Citing Joel C. Barrish

Trending Scientists

Recently Published Articles